CoChat

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review

Open access
Dos Santos, Gael, Tahrat, Halima, Bekkat-Berkani, Rafik · 2018 · Human Vaccines & Immunotherapeutics

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Influenza is associated with an increased risk of complications, especially in diabetic mellitus patients who are more susceptible to influenza infection. Despite recommendations of the WHO and public health authorities, vaccination uptake in this population remains suboptimal. This systematic review identified 15 studies published between January 2000-March 2017 in PubMed, Embase and Cochrane Library, which provided data on immunogenicity, safety, effectiveness, and/or cost-effectiveness of seasonal influenza vaccination in diabetic patients. Immunogenicity of seasonal influenza vaccination in diabetic patients was generally comparable to that of healthy participants. One month after vaccination of diabetic patients, seroconversion rates and seroprotection ranged from 24.0-58.0% and 29.0-99.0%, respectively. Seasonal influenza vaccination reduced the risk of hospitalization and mortality in diabetic patients, particularly those aged ≥65 years. These review results demonstrate and reinforce the need and value of annual influenza vaccination in diabetic patients, particularly in alleviating severe complications such as hospitalization or death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21645515.2018.1446719

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Flow chart summarizing the systematic literature search and study selection process.
Figure 1. Flow chart summarizing the systematic literature search and study selection process.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 2

  1. World Health Organization, 2003, Prevention and control of influenza pandemics and annual epidemics
  2. Villarroel MA, 2016, NCHS Data Brief., 1

Cited by

See all 90

Metadata

Authors
Dos Santos, G., Tahrat, H., & Bekkat-Berkani, R.
Affiliations
  • GSK, Wavre, Belgium
  • GSK, Rockville, MD, USA
  • GlaxoSmithKline (United States) (US)
Venue
Human Vaccines & Immunotherapeutics
Published
2018-04-09
Volume
14
Issue
8
Pages
1853-1866
ISSN
  • 2164-5515 (ISSN-L)
  • 2164-554X
OpenAlex
W2793270909
Cited by
83
References
34
Citations by year
2026: 2 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 17 · 2021: 11 · 2020: 10 · 2019: 6 · 2018: 3
FWCI
1.07
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Human Vaccines & Immunotherapeutics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
seasonal influenza vaccination, diabetes mellitus, immunogenicity, vaccine safety, vaccine effectiveness, seroconversion, seroprotection, hospitalization, mortality, cost-effectiveness, vaccine uptake
MeSH terms
Immunogenicity, Vaccine, Cost-Benefit Analysis, Diabetes Mellitus, Humans, Influenza, Human, Influenza Vaccines, Influenza A virus, Quality of Life, Seasons, Vaccination, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review. https://app.cochat.ai/papers/10.1080/21645515.2018.1446719
The paper
Dos Santos, G., Tahrat, H., & Bekkat-Berkani, R. (2018). Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2018.1446719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.